Replies to Have you checked to see if we might be eligible to join the clinical trial :-)

← Return to Oral teriparatide tablet (EB613) gets FDA nod for Phase 3 trial

Discussion

Oral teriparatide tablet (EB613) gets FDA nod for Phase 3 trial

Osteoporosis & Bone Health | Last Active: Jun 30 2:13pm | Replies (28)

Comment receiving replies

@tillymack

Have you checked to see if we might be eligible to join the clinical trial 🙂

Jump to this post

Replies to "Have you checked to see if we might be eligible to join the clinical trial :-)"

mayblin | @mayblin | Jun 25 8:02am

@tillymack
I don't believe recruitment has started yet. You could periodically check ClinicalTrials.gov later this year once they post the inclusion/exclusion criteria. For now, their Phase 2 criteria give a general idea,mthough Phase2 was conducted only in Israel since this is an Israel based company. Phase 3 is larger and will likely be multinational.

Unrelated, but if you or anyone is interested in anabolic therapy sooner, MGH (Mass General) in Boston is actively recruiting for a Phase 4 trial combining teriparatide (Forteo) and romosozumab (Evenity).

VIEW AND REPLY

md79 | @md79 | Jun 27 11:53pm

@tillymack I am very much interested if we might enroll to this clinical trial. I was prescribed teriperitide 3 days ago, but I most possibly need financial help to pay for it after my insurance coverage. Does anybody know if any help is available and where to look up?

VIEW AND REPLY